Positive Delegate Experiences at BOS cmc 2017, June, Basel
18th September 2017
Comments from Attendees following BOS cmc 2017 which took place on the 27th and 28th of June at the Conference Centre Basel, Switzerland.

The conference was an excellent opportunity to meet a variety of CMOs in the DS/DP field and have sufficient time for discussion. The timetables available prior to the meeting were a very helpful tool in setting the meetings. The talks I attended during the sessions were informative and the diversity of attendees and presenters represented a wide cross section of the industry.
Mirjam Sax, PhD, Principal Site Manager, External Development Collaborations, PTDMX Small Molecules, F. Hoffmann-La Roche Ltd

The Bio 2 Business conference has been growing from strength to strength year on year. The presentation session are very educational and very well perceived by the Pharma, Biotec and services companies. There is also a great opportunity to network. Overall this conference is an unique opportunity to collaborate we all parties present.
Michael Kruidenier , Head of Business Development, Quay Pharma.


BOS CMC has become the most important partnering event in my annual calendar – a great opportunity to catch up with existing collaborators and to forge new business relationships.
Dr Andy Baxter, Director & Discovery and Development Consultant
ProPharma Partners Ltd


BOS cmc 2017 was another successful event for AMRI. The organisation of the event, and pre-communication with the BOS event team, as always, was excellent. Conducive venue, with great service. The ‘easy to use’ electronic meeting system allows for meetings, with existing and new customers, to be pre-arranged. There is also great networking opportunities to meet up with customer, colleagues and friends. The ROI is always good from this event, so we will be attending again next year.
Doreen Coull, Regional Sales Director, Albany Molecular Research Inc


Very interesting event for specific networking and selective information sourcing on CROs and CMOs. Very informative talks from experts with many relevant case studies Good size and venue.
Mario Amacker, PhD, Head of Quality & Manufacturing, Mymetics BV

BOS CMC 2017 was a very informative congress which allows one 2 one meeting with CMOs and other collaborators, which is quite unique compared to other congresses. The topics covered in this congress were also very interesting and provided insight to all the relevant challenges regularly faced by biotech companies during outsourcing activities. Overall the event was organized meticulously by the organizers.
Yogeshwar Bachhav, Associate Director Pharmaceutical Development, Aicuris GmbH

BOS2017 in Basel was, as always, a great event to attend.
A nice venue combined with a wide selection of vendors and relevant lectures by inspired speakers. For such an event it is a success if I return with a handful of new potential vendors and BOS was indeed a success.
Frederik Barfoed Beck, Senior Outsourcing Manager, Zealand Pharma

BOS provides excellent partnership and networking opportunities for small to mid-sized pharmaceutical companies and organisations. The conference programme of insightful presentations and workshops delivered by industry experts is a great platform for both sharing and advancing knowledge.
Laura Millichamp, Director, CMC & Quality, Voisin Consulting Life Sciences

BOS cmc is a relevant event to meet customers. The event, well organized, has a good mixture of presentations and partnering opportunities.”
Joost Cornelissen, Business Development Manager, BioConnection B.V.

BOS cmc was a very interesting conference with a high number of interesting speeches in both small and largemolecule space. The think I like the most is the nice combination between each speech, the one-to-one meetings and the possibility to speak to companies at each stand without having an excess number of participants.
Michele Gandellini | Account Manager, EIA | Transformational Health | Frost & Sullivan

Biotech Outsourcing Strategies CMC is a very well organised and highly focused event, bringing together drug developers with relevant service providers. The partnering format is ideal as it gives plenty of opportunities to meet and discuss collaborations with new and existing contacts, while still leaving ample time for more informal networking and presentations. This has been a very successful event for us!
Dr Nathalie Huther, Business Development Manager Europe, ACRINOVA

I would like to thank you again for the opportunity of joining this exciting event. BOS cmc is the place where Analytical CROs meet CMOs together with outsourcing professionals! Because of its relatively small size, you can have the opportunity of knowing more providers experiencing their approach on the main CRO/CMO activities.
Gabriele Sassi, Non Clinical Outsourcing Manager, R&D Outsourcing Management, CHIESI FARMACEUTICI S.p.A.


Bio2business CMC has found a splendid location and continued to develop an already impressive partnering and lecture event. I have said before that this is the go to partnering event of the year for me and this continues to be the case. Pleasant surroundings, inspirational lectures and an excellent selection of meetings.
Paul Little, COO, NMD Pharma ApS

2017 was my first attendance at BOS and I enjoyed it very much. This seminar was a great time to meet with CMOs in a quiet and relaxed atmosphere. It's been a great opportunity to hear from other's experience and challenges. The human size of BOS allowed an interesting networking and fruitful discussions with our partners. I'm sure to be part of the 2018 session. Many thanks for the good organization.
Carole Mainguet / CMO site manager / PT Development, External Manufacturing F.Hoffmann-La Roche Ltd